Lupin bags USFDA approval for Fesoterodine Fumarate ER Tablets Ruchika Sharma10 Jan 2023 3:22 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Spain approves reimbursement of Lupin NaMuscla for symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders Ruchika Sharma10 Jan 2023 11:35 AM ISTNDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and is...
Lupin unveils fixed-dose triple drug combination DIFIZMA DPI for inadequately controlled asthma Ruchika Sharma6 Jan 2023 11:38 AM IST"DIFIZMA is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled Asthma,"...
Lupin arm recalls high BP drug Quinapril in US over presence of nitrosamine impurity Ruchika Sharma23 Dec 2022 12:30 PM ISTThe company advised patients taking the Quinapril tablets "to continue taking their medication and contact their pharmacist, physician, or medical...
Lupin Diagnostics launches Regional Reference Laboratory in Indore Ruchika Sharma21 Dec 2022 4:22 PM ISTIndore: Pharma major Lupin Limited announced today the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its...
Lupin bags USFDA nod for generic equivalent of Briviact Tablets Ruchika Sharma21 Dec 2022 1:45 PM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
Lupin unveils generic version of joint pain drug PENNSAID in US Ruchika Sharma9 Dec 2022 2:49 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution),...
Spiro Gavaris appointed as President of Lupin's US Generics Business Ruchika Sharma9 Dec 2022 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the appointment of Spiro Gavaris as President U.S. Generics business. As part of Lupin's...
Lupin rolls out Seizure drug Rufinamide in US Ruchika Sharma5 Dec 2022 3:15 PM ISTMumbai: Pharma major Lupin Limited today announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg in the United States market.The...
Lupin arm acquires right to Limbitrol, Bacrocin and 7 other medicines from Bausch Health Ruchika Sharma29 Nov 2022 2:00 PM ISTMumbai: Global pharma major, Lupin Limited has announced that the company's wholly-owned subsidiary in Brazil, MedQuÃmica Indústria Farmacêutica, has...
Lupin unveils generic equivalent of Perforomist Inhalation Solution in US Ruchika Sharma29 Nov 2022 12:00 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial in...
Lupin gets 8 USFDA observations for Mandideep facility Ruchika Sharma25 Nov 2022 11:00 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with eight observations each...
